• to decrease the potential risk of really serious cardiovascular (coronary heart and blood vessel) difficulties in Grown ups with form 2 diabetes and cardiovascular diseaseNovo Nordisk A/S is usually a Danish multinational pharmaceutical company headquartered in Bagsværd,[3] with manufacturing amenities in nine countries and affiliate marketers